Cardiology - European Medical Journal

Continue

Cardiology

Filter
5 Mins
9 Dec 2021

Aficamten: A New Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy

REDWOOD-HCM was a multicentre, randomised, placebo-controlled, double-blind, dose-finding clinical trial of aficamten in patients with symptomatic oHCM on background medical therapy.
10 Mins
9 Dec 2021

Automated Echocardiography Analysis: Expanding Access and Saving Time

December marks the launch of Us2.ai’s automated cardiac analysis platform1 as a cloud-based service on the EchoNous Kosmos device…
12 Mins
9 Dec 2021

Current Therapy for Homozygous Familial Hypercholesterolaemia

Homozygous familial hypercholesterolaemia (HoFH) is a rare and aggressive disorder, resulting from the inheritance of mutations in the two alleles of genes regulating the low-density lipoprotein receptor (LDL-R) function.
2 Mins
11 Oct 2021

Interview: Rebecca Dobson

One of my first ‘house jobs’ was in cardiology, in a District General Hospital, with two great Consultants, one male and one female…
EMJ Cardiology feature image
10 Mins
11 Oct 2021

New Therapies for Patients Following a Worsening Heart Failure Event? What’s Next for Your Patients Following a Worsening Heart Failure Event?

Patients with HF embark on a vicious cycle characterised by progressive worsening over time, recurrent hospitalisations associated…
11 Mins
11 Oct 2021

Paroxysmal Supraventricular Tachycardia: Highlighting Unmet Needs in Emergency Care

The clinical syndrome of paroxysmal supraventricular tachycardia (PSVT) is characterised by recurrent, acute episodes of rapid heart rate…
9 Mins
11 Oct 2021

Editor’s Pick: Association Between the Hospital Readmissions Reduction Program and Heart Failure Subtype Readmissions and Mortality in the USA

The Hospital Readmissions Reduction Program (HRRP) was designed to penalise hospitals for excess readmission…
10 Mins
11 Oct 2021

Biomarker-Based Guideline-Directed Medical Therapy of Heart Failure

The prevalence of heart failure (HF) worldwide is 64.34 million cases, and almost 10 million years have been lost due to HF-related disability…